Cytotoxic mechanism of selenomethionine in yeast.
Although selenium is an essential element, its excessive uptake is detrimental to living organisms. The significance of selenium for living organisms has been exploited for various purposes. However, the molecular basis of selenium toxicity is not completely understood. Here, we applied a capillary electrophoresis time-of-flight mass spectrometry-based metabolomics approach to analysis of yeast cells treated with selenomethionine. The data indicated that intracellular thiol compounds are significantly decreased, and diselenide and selenosulfide compounds are increased in selenomethionine-treated cells. The growth defect induced by selenomethionine was recovered by extracellular addition of cysteine and by genetic modification of yeast cells that have an additional de novo synthetic pathway for cysteine. Because cysteine is an intermediate of thiol compounds, these results suggested that the loss of a reduced form of thiol compounds due to selenomethionine causes a growth defect of yeast cells.
Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology, Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan.
Toshihiko
T
Kitajima
Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology, Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan.
Yoshifumi
Y
Jigami
Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology, Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan. Electronic address: y-chiba@aist.go.jp.
Yasunori
Y
Chiba
D003545:Cysteine / Q000494:pharmacology; D003603:Cytotoxins / Q000494:pharmacology*; D055432:Metabolomics / Q000379:methods; D012441:Saccharomyces cerevisiae / Q000235:genetics / Q000254:growth & development / Q000378:metabolism*; D012645:Selenomethionine / Q000494:pharmacology*
D003603:Cytotoxins; D012645:Selenomethionine; D003545:Cysteine